UA96476U - APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION - Google Patents

APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION

Info

Publication number
UA96476U
UA96476U UAU201408681U UAU201408681U UA96476U UA 96476 U UA96476 U UA 96476U UA U201408681 U UAU201408681 U UA U201408681U UA U201408681 U UAU201408681 U UA U201408681U UA 96476 U UA96476 U UA 96476U
Authority
UA
Ukraine
Prior art keywords
application
correction
corporation
carbethoxy
triazolo
Prior art date
Application number
UAU201408681U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Nataliia Heorhiivna Malova
Fedir Heorhiiovych Yaremenko
Loriana Yuriivna Serhiienko
Iryna Volodymyrivna Komarova
Volodymyr Mykolaiovych Vakula
Larysa Anatoliivna Syrotenko
Nataliia Mykhailivna Brechka
Yuliya Sergiivna Kurilko
Olga Valeriivna Steblina
Andrii Volodymyrovych Spyrydonov
Yana Olegivna Muntyanu
Tetiana Viktorivna Bondarenko
Hanna Mykolaivna Cherevko
Liubov Mykolaivna Tolmachova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201408681U priority Critical patent/UA96476U/en
Publication of UA96476U publication Critical patent/UA96476U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Застосування 7-(3-гідроксифеніл)-6-карбетокси-5-метил-4,7-дигідро[1,2,4]триазоло-[1,5-а]піримідину для корекції порушень структури кісткової тканини при гіпотиреоїдних станах. Вводять у дозі 10 мг/кг перорально у 2 % крохмальному розчині протягом 10 діб.The use of 7- (3-hydroxyphenyl) -6-carbethoxy-5-methyl-4,7-dihydro [1,2,4] triazolo- [1,5-a] pyrimidine for the correction of bone structure disorders in hypothyroid states. It is administered at a dose of 10 mg / kg orally in 2% starch solution for 10 days.

UAU201408681U 2014-07-31 2014-07-31 APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION UA96476U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201408681U UA96476U (en) 2014-07-31 2014-07-31 APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201408681U UA96476U (en) 2014-07-31 2014-07-31 APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION

Publications (1)

Publication Number Publication Date
UA96476U true UA96476U (en) 2015-02-10

Family

ID=52989481

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201408681U UA96476U (en) 2014-07-31 2014-07-31 APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION

Country Status (1)

Country Link
UA (1) UA96476U (en)

Similar Documents

Publication Publication Date Title
PH12018500041A1 (en) Substituted aza compoounds as irak-4 inhibitors
EA201990519A1 (en) CRYSTALLINE FORM (S) -7- (1-ACRYLOYLPIPERIDIN-4-IL) -2- (4-PHENOXYPHENYL) -4,5,6,7-TETHRHYDROPYRAZOLO [1,5-a] PYRIMIDIN-3-CARBOXAMIDE, ITS PRODUCTION AND APPLICATIONS
EA201790995A1 (en) PYRAZOLO [1,5-a] SUBSTITUTED PYRIMIDINES AND THEIR APPLICATION IN THE TREATMENT OF DISEASES
PH12015502780B1 (en) Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
CL2013003051A1 (en) Compounds derived from pyrazolo (4.3-d) pyrimidines, kinase inhibitors; pharmaceutical composition; and use for the treatment of diseases and disorders of the respiratory system
MX2021013118A (en) Polyfluorinated compounds acting as bruton's tyrosine kinase inhibitors.
EA202090291A3 (en) BIPIRAZOLE DERIVATIVES AS JAK INHIBITORS
MA40236A (en) Crystalline forms of (2r,5s,13ar)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido [1',2':4,5] pyrazino [2,1-b] [1,3] oxazepine-10-carboxamide
MX370814B (en) Substituted pyrazolo[3,4-d]pyrimidines and uses thereof.
MX2017012411A (en) Co-crystals of a bruton's tyrosine kinase inhibitor.
CY1121649T1 (en) 6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZINE-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODIFIERS OF MGLU2 RECEPTORS
CY1121123T1 (en) COMPOUNDS 6,7-DIHYDROPYRAZOL [1,5-A] PYRAZIN-4 (5H) -ONE AND THEIR USE AS NEGATIVE ALLOSTERER MODELS OF MGLU2 RECEPTORS
MX2016015762A (en) Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain.
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
EA201792057A1 (en) CONDENSED BICYCLIC HETEROYARIL DERIVATIVES WITH ACTIVITY OF PROHYLDROXYLASE INHIBITORS
EA201790603A1 (en) Inhibitors of histonedehylase
HUE056561T2 (en) Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives
SI3596080T1 (en) Pharmacologically active alicyclic-substituted pyrazolo(1,5-a)pyrimidine derivatives
EA201692371A1 (en) 1H-1,8-NAFTYRIDIN-2-ONE AS ANTIPROLIFERATIVE COMPOUNDS
UA96476U (en) APPLICATION OF THE APPLICATION OF THE CORPORATION OF THE CORRECTION CORRECTION OF THE APPLICATION OF THE INVENTION
PT3277687T (en) 7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine derivatives which are useful for the treatment of immune or inflammatory diseases or cancer
PH12016502540A1 (en) Pharmaceutical dosage forms
IL253427B (en) Pyrazolo[3,4-d]pyrimidin derivative and its use for the treatment of leishmaniasis
TH1601003657A (en) [1,2,4]triazolo[1,5-A]pyrimidine derivatives As proteasome inhibitors of Protozoa for the treatment of diseases caused by parasites such as leishmaniasis.
MY192305A (en) Bipyrazole derivatives as jak inhibitors